Chen, Tina H;
Wu, Steve W;
Welge, Jeffrey A;
Dixon, Stephan G;
Shahana, Nasrin;
Huddleston, David A;
Sarvis, Adam R;
Sallee, Floyd R;
Gilbert, Donald L
Reduced Short Interval Cortical Inhibition Correlates With Atomoxetine Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
Sie können Bookmarks mittels Listen verwalten, loggen Sie sich dafür bitte in Ihr SLUB Benutzerkonto ein.
Medientyp:
E-Artikel
Titel:
Reduced Short Interval Cortical Inhibition Correlates With Atomoxetine Response in Children With Attention-Deficit Hyperactivity Disorder (ADHD)
Beteiligte:
Chen, Tina H;
Wu, Steve W;
Welge, Jeffrey A;
Dixon, Stephan G;
Shahana, Nasrin;
Huddleston, David A;
Sarvis, Adam R;
Sallee, Floyd R;
Gilbert, Donald L
Erschienen:
SAGE Publications, 2014
Erschienen in:
Journal of Child Neurology, 29 (2014) 12, Seite 1672-1679
Beschreibung:
Clinical trials in children with attention-deficit hyperactivity disorder (ADHD) show variability in behavioral responses to the selective norepinephrine reuptake inhibitor atomoxetine. The objective of this study was to determine whether transcranial magnetic stimulation–evoked short interval cortical inhibition might be a biomarker predicting, or correlating with, clinical atomoxetine response. At baseline and after 4 weeks of atomoxetine treatment in 7- to 12-year-old children with ADHD, transcranial magnetic stimulation short interval cortical inhibition was measured, blinded to clinical improvement. Primary analysis was by multivariate analysis of covariance. Baseline short interval cortical inhibition did not predict clinical responses. However, paradoxically, after 4 weeks of atomoxetine, mean short interval cortical inhibition was reduced 31.9% in responders and increased 6.1% in nonresponders (analysis of covariance t41 = 2.88; P = .0063). Percentage reductions in short interval cortical inhibition correlated with reductions in the ADHD Rating Scale ( r = 0.50; P = .0005). In children ages 7 to 12 years with ADHD treated with atomoxetine, improvements in clinical symptoms are correlated with reductions in motor cortex short interval cortical inhibition.